Trial Profile
A Double Blind Randomized Control Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Interstitial lung diseases; Scleroderma
- Focus Therapeutic Use
- 12 May 2015 New trial record